LAWRENCE DAVID 4
4 · ACORDA THERAPEUTICS INC · Filed Mar 12, 2019
Insider Transaction Report
Form 4
LAWRENCE DAVID
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-03-08+15,075→ 15,075 totalExercise: $13.51Exp: 2029-03-08→ Common Stock (15,075 underlying) - Award
Common Stock
2019-03-08+9,045→ 14,137 total
Footnotes (2)
- [F1]Restricted shares issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares will vest 25% every year for four years with vest dates of December 1, 2019, December 1, 2020, December 1, 2021 and December 1, 2022.
- [F2]Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2019 with the first quarterly installment vesting on April 1, 2019.